Valerie Speirs

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Male Breast Neoplasms 73%
3. Neoplasms 30%
4. Tamoxifen 29%
5. Breast 29%
6. Estrogen Receptors 28%
7. Survival 17%
8. Estrogen Receptor alpha 17%
9. Biomarkers 17%
10. Protein Isoforms 12%
11. Fibroblasts 11%
12. Androgen Receptors 11%
13. Translational Medical Research 10%
14. Carcinoma, Intraductal, Noninfiltrating 10%
15. Cell Line 10%
16. Disease-Free Survival 9%
17. Recurrence 9%
18. MicroRNAs 9%
19. Chromosomal Instability 8%
20. Proteins 8%
21. Biomedical Research 8%
22. Progesterone Receptors 8%
23. Hormones 7%
24. Transducers 7%
25. exemestane 7%
26. Epigenomics 7%
27. Epithelial Cells 6%
28. Ductal Carcinoma 6%
29. Androgen Antagonists 6%
30. Therapeutics 6%
31. Immunohistochemistry 6%
32. In Vitro Techniques 6%
33. Molecular Pathology 6%
34. Cancer-Associated Fibroblasts 5%
35. Cytokinesis 5%
36. Research Personnel 5%
37. Steroid Receptors 5%
38. Pathology 5%
39. Down-Regulation 5%
40. Bone Development 5%
41. Proteomics 5%
42. Clinical Trials 5%
43. 5' Untranslated Regions 5%
44. Animal Models 5%